VIDEO: IBM (NYSE:IBM) To Acquire Real Estate Management Software Company Tririga

IBM (NYSE:IBM) is making its first purchase of 2011. Big Blue is acquiging the real estate management software developer Tririga. Financial terms of the deal, which is expected to close in the second quarter of 2011, were not disclosed. Tririga’s software helps clients make strategic planning decisions regarding space usage, evaluates alternative real estate initiatives, generates higher returns from capital projects and assesses environmental impact investments. Tririga’s software is used by more than 200 clients, including over one-third of Fortune 100 corporations as well as seven of the 15 federal executive departments of the U.S. government The company will be integrated into IBM Tivoli Software and IBM Global Business Services. In 2010, IBM spent roughly $6 Billion to acquire 17 companies. IBM numbers are up just over a quarter or .17% to $157.95.

Continue reading

Big Movers: Avago Technologies Limited (NASDAQ:AVGO), Gilead Sciences Inc. (NASDAQ:GILD), Intel Corporation (NASDAQ:INTC), Bristol-Myers Squibb Company (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN)

Avago Technologies (NASDAQ:AVGO) is set to post its quarterly earnings results on Wednesday, December 3rd. Avago Technologies Limited (NASDAQ:AVGO) in last trading activity fell -0.41% to close at $93.40. Company weekly performance is 3.86% while its quarterly performance stands at 14.19%. Avago Technologies Limited (NASDAQ:AVGO) is -0.49% away from its 52 week high.

Gilead Sciences Inc. (NASDAQ:GILD) says it has reached a deal with several generic drugmakers to produce cheaper versions of its popular, expensive hepatitis C drug Sovaldi for use in developing countries. On last trading day Gilead Sciences Inc. (NASDAQ:GILD) increased 0.02% to close at $100.32. Its volatility for the week is 2.34% while volatility for the month is 2.83%. GILD’s sales growth for past 5 years was 16.00% and its EPS growth for past 5 years was 11.90%. Gilead Sciences Inc. (NASDAQ:GILD) monthly performance is -9.39%.

Google and Intel Corporation (NASDAQ:INTC) are partnering on the next version of Google Glass, according to a report in the Wall Street Journal. Intel Corporation (NASDAQ:INTC) in last trading activity increased 0.95% to close at $37.25. Company weekly performance is 3.62% while its quarterly performance stands at 7.38%. Intel Corporation (NASDAQ:INTC) is 0.70% away from its 52 week high.

U.S. regulators have declined to approve Bristol-Myers Squibb Company (NYSE:BMY)’s daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir. On last trading day Bristol-Myers Squibb Company (NYSE:BMY) increased 0.32% to close at $59.05. Its volatility for the week is 1.22% while volatility for the month is 1.66%. BMY’s sales growth for past 5 years was -1.50% and its EPS growth for past 5 years was -3.60%. Bristol-Myers Squibb Company (NYSE:BMY) monthly performance is 9.03%.

Regeneron Pharmaceuticals (NASDAQ:REGN) Director Alfred G. Gilman unloaded 40,000 shares of Regeneron Pharmaceuticals stock on the open market in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $408.44, for a total value of $16,337,600.00. On Friday shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) closed at $416.11. Company’s sales growth for last 5 years was 54.60% and EPS growth for next 5 years is recorded as 20.11%.